Partial vs. sequential tests in WNL [Software]

posted by Helmut Homepage – Vienna, Austria, 2014-07-01 14:26 (3957 d 17:06 ago) – Posting: # 13187
Views: 27,420

Hi Zan,

❝ The document #98-392 is hidden in page 52 of the PDF file […].


It took the FDA until Sep 1999 to answer a letter received in Oct 1998. Note that this was well before the 2001 Stat. Guidance. Amazingly the letter deals with a one-week (!) washout and the same interval between groups.
┌───────────────┬──────────┬──────────┬──────────┬──────────┐
│ Dosing Scheme │   11/1   │   11/8   │   11/15  │   11/22  │
├───────────────┼──────────┼──────────┼──────────┼──────────┤
│       1       │  Group 1 │  Group 1 │  Group 2 │  Group 2 │
│               │ Period 1 │ Period 2 │ Period 1 │ Period 2 │
├───────────────┼──────────┼──────────┼──────────┼──────────┘
│       2       │  Group 1 │  Group 1 │          │
│               │ Period 1 │ Period 2 │          │
│               │          │  Group 2 │  Group 2 │
│               │          │ Period 1 │ Period 2 │
└───────────────┴──────────┴──────────┴──────────┘

It’s interesting that the FDA stated:

1. Both Dosing Schemes are acceptable to the Division of Bioequiva-
    lence.

With the second scheme you’ll have the entire bunch of sub­jects at the cli­ni­cal site on the second day. That’s bizarre; I don’t get it. If the CRO is large enough, why deal with two groups at all?

I would not bother about #1–8 and rather con­cen­trate on

9. If ALL of the following criteria are met, it may not be necessary to
    include Group-by-Treatment in the statistical model:

  • the clinical study takes place at one site;
  • all study subjects have been recruited from the same enrollment pool,
  • all of the subjects have similar demographics;
  • all enrolled subjects are randomly assigned to treatment groups at study outset.

In this latter case, the appropriate statistical model need include only the factors Sequence, Period, Treatment, and Subject (nested within Sequence).


❝ Also, in PHX winnonlin, should partial test or sequential test the best approach to look for all the stat test results (eg. Group, treatment, period effect)? I tend to go with partial test as it is tested independent of order but not sure if I am correct.


‘Partial Tests’ are expected to agree with SAS’ Type III LSMs in most of cases (whereas ‘Sequential Tests’ ≡ SAS’ Type I). See the “Phoenix User’s Guide” Table 17-13 (p448–50 = p478–80 of the PDF).

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
63 visitors (0 registered, 63 guests [including 5 identified bots]).
Forum time: 07:33 CEST (Europe/Vienna)

We must be careful not to confuse data with the abstractions
we use to analyze them.    William James

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5